Nina Tamirisa is an Assistant Professor at The University of Texas MD Anderson Cancer Center. Her research focuses on breast cancer surgical oncology, specifically de-escalation of surgical and radiation therapies for low-risk disease. Her recent work includes a phase II trial evaluating definitive stereotactic ablative radiotherapy with endocrine therapy for select low-risk breast cancers, validation of a prognostic staging system incorporating age at diagnosis, and implications of omitting sentinel lymph node biopsy in early-stage node-negative HR+/HER2− breast cancer. She also investigates pathologic nodal disease prediction and treatment sequencing for older women with comorbidities. Her publications appear in Radiotherapy and Oncology, Cancer, and npj Breast Cancer.
See moreHonors

Experiences

Education
